Atea Pharmaceuticals, Inc. — Director's Dealing 2021

May 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2021-05-18

Reporting Person: Adams Jerome M. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-18	Stock Option (Right to Buy)	$23.43	A	56670	Acquired	2031-05-17	Common Stock (56670)	Direct

Footnotes

F1: The option vests and becomes exercisable in thirty-six (36) equal monthly installments following May 18, 2021.